Beyond its role of cellular energy currency and phosphate donor, ATP plays a potent signaling role through its extracellular release and activation of cell surface purinergic receptors. 1,2 Fast responses to ATP are mediated through activation of P2X receptors, 3 a family (P2X 1 -P2X 7 ) of
and P2X 7 are the dominant P2X subtypes present. Activation of purinergic receptors in leukocytes is coupled to the production and secretion of cytokines and other proinflammatory molecules including prostaglandin E2. 4 Purinergic receptors are associated with inflammation, with some receptors inhibited either directly (P2Y 12 ) or indirectly through the activity of antithrombotic, in the case of platelet P2Y 12 , or anti-inflammatory agents, in the case of the action of statins on monocyte P2X 4 .
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ATP can act as a non-peptide damageassociated molecular pattern (DAMP) release from injured cells and tissues. In this fashion the release of cellular ATP is unregulated and released due to cell lysis or puncture. Cell surface purinergic receptors are activated by this ATP DAMP signal which serves to initiate an inflammatory response and promote wound healing. However, ATP can be released from cells physiologically and act as a critical signal for painful, inflammatory processes. Cells do release other nucleotides including UTP and UDP-sugars but our focus here is ATP release. Mechanisms of ATP release during physiological processes remain diverse and controversial.
ATP Release Mechanisms in Leukocytes
Routes of ATP release in mammalian cells remain diverse and often controversial. 14,18 The mechanism of lysosomal ATP transport remains undefined though a nucleotide transporter (V-NUT) has been characterized for other ATP containing vesicles. 19 There is also evidence that astrocytes release ATP through lysosome exocytosis.
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Future Investigation
The signal transduction coupling external cues such as cytokines, chemokines and bacterially derived molecules to ATP release is poorly defined. What are the release machines in leukocytes and do they differ from other cell types? It is expected that therapeutic intervention in agonist stimulated ATP release is a potentially novel route to pharmacological modulation of innate immune responses but also in chronic inflammatory disease where normal inflammatory responses are heighten and act deleteriously.
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Investigation into how cellular stress stimulates ATP release in non-leukocytes suggests roles for connexin and pannexin hemichannels, 6 ,7 maxi-and volume-regulated anion channels 8, 9 and efflux through the P2X 7 receptor, 10 though release routes and signal transduction mechanism underlying ATP release in leukocytes remain poorly defined.
Agonist Stimulated ATP Release
In neutrophils ATP is released in response to activation of fMLP receptor by bacterially derived N-formylmethionine. 11 The precise release mechanism is unclear but occurs at the leading edge of migrating neutrophils. Released ATP and its subsequent metabolism to adenosine at the cell surface activate P2Y 2 and A 3 receptors serving to direct cell orientation and promote migration in response to chemotactic signals.
11 Bacterially derived lipopolysaccharide can stimulate central microglia to secrete ATP which in-turn activates neighboring astrocytes and modulates excitatory neurotransmission.
12 In endothelial cells and microglia, extracellular ATP itself can stimulate ATP release. 13, 14 This raises the possibility that ATP can act in a feed forward loop possibly amplifying responses to itself or other external cues which couple to ATP secretion. An autocrine feed forward mechanism has been described in epithelial cells.
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Lysosomes as ATP Release Machines
Our recent study by Sivaramakrishnan et al. (2012) demonstrated that human monocytes secrete ATP in a constitutive fashion. 16 Furthermore, such constitutive secretion leads to activation of cell surface G q -coupled P2Y receptors which elevate intracellular calcium levels through release of calcium. 16 This mode of constitutive secretion generates a constant pericellular ATP cloud or "halo" which appears to be important in regulating intracellular calcium homeostasis following P2Y receptor activation. 16 In cells of hematopoietic lineage such as monocyte/macrophage, NK
